NSCLC patients with MET non-exon-14 mutations rather than MET exon 14 mutations response to immune checkpoint inhibitors
| Autor: | Li, Xuanzong *, Liu, Jie, Guo, Meiying, Cai, Hongchao, Chen, Dawei ** |
|---|---|
| Zdroj: | In Lung Cancer February 2021 152:202-204 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect